CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-11 | BIENAIME JEAN JACQUES Director | Sale 10b5-1 | −20,000 | $90.99 | $1.8M | 474,994 |
| 2024-04-11 | BIENAIME JEAN JACQUES Director | Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 | −20,000 | 111,000 | ||
| 2024-04-10 | Burkhart Erin GVP, Chief Accounting Officer | Sale 10b5-1 | −2,286 | $90.00 | $206K | 16,156 |
| 2024-03-28 | Davis George Eric EVP, Chief Legal Officer | Sale 10b5-1 | −24,602 | $88.34 | $2.2M | 55,856 |
| 2024-03-18 | Slamon Dennis Director | Option exercise | +10,000 | $79.70 | $797K | 40,809 |
| 2024-03-18 | Slamon Dennis Director | Shares withheld for taxes | −9,510 | $83.81 | $797K | 31,299 |
| 2024-03-18 | Slamon Dennis Director | Option exercise · Stock Option (Right to Buy Common Stock) | −10,000 | 0 | ||
| 2024-03-18 | Burkhart Erin GVP, Chief Accounting Officer | Shares withheld for taxes | −372 | $83.87 | $31K | 18,442 |
| 2024-03-15 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award | +4,720 | 18,814 | ||
| 2024-03-15 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +7,050 | 7,050 | ||
| 2024-03-15 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +10,260 | 102,157 | ||
| 2024-03-15 | Davis George Eric EVP, Chief Legal Officer | Shares withheld for taxes | −21,699 | $83.87 | $1.8M | 80,458 |
| 2024-03-15 | Davis George Eric EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +22,990 | 22,990 | ||
| 2024-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +10,550 | 98,751 | ||
| 2024-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −20,424 | $83.87 | $1.7M | 78,327 |
| 2024-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +23,630 | 23,630 | ||
| 2024-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +11,400 | 92,648 | ||
| 2024-03-15 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −20,789 | $83.87 | $1.7M | 71,859 |
| 2024-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +25,540 | 25,540 | ||
| 2024-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +18,240 | 230,357 |
Page 9 of 10 · 187 trades